Home NDC 59762-4537 medroxyprogesterone acetate
Product NDC 59762-4537
11-digit product format 597624537
Labeler code 59762
Product ID 59762-4537_5887c59f-4735-42d2-8780-2b17ae4ed18c
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name medroxyprogesterone acetate
Dosage form INJECTION, SUSPENSION
Route INTRAMUSCULAR
Labeler Greenstone LLC
Application NDA020246
Marketing category NDA AUTHORIZED GENERIC
Marketing start 1992-10-29
Marketing end 0000-00-00
Substance MEDROXYPROGESTERONE ACETATE
Active strength 150 mg/mL
Pharmacologic classes Progesterone Congeners [CS],Progestin [EPC]
NDC exclude flag No
Listing certified through 2022-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 36 matching rows.
View current auxiliary records. · View the auxiliary file history.
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N020246-001 DEPO-PROVERA MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N020246-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N020246-001 DEPO-PROVERA 150MG/ML INJECTABLE / INJECTION AB RLD, RS 1992-10-29 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
DailyMed Product Concepts# DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded MEDROXYPROGESTERONE ACETATE ACTIVE INGREDIENT C2QI4IOI2G MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [GREENSTONE LLC] 17 MEDROXYPROGESTERONE ACTIVE MOIETY HSU1C9YRES MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [GREENSTONE LLC] 17 HYDROCHLORIC ACID INACTIVE INGREDIENT QTT17582CB MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [GREENSTONE LLC] 17 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [GREENSTONE LLC] 17 POLYETHYLENE GLYCOL 3350 INACTIVE INGREDIENT G2M7P15E5P MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [GREENSTONE LLC] 17 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [GREENSTONE LLC] 17 PROPYLPARABEN INACTIVE INGREDIENT Z8IX2SC1OH MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [GREENSTONE LLC] 17 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [GREENSTONE LLC] 17 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [GREENSTONE LLC] 17 WATER INACTIVE INGREDIENT 059QF0KO0R MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [GREENSTONE LLC] 17 medroxyprogesterone acetate ACTIVE INGREDIENT C2QI4IOI2G MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PREFERRED PHARMACEUTICALS, INC] 7 medroxyprogesterone ACTIVE MOIETY HSU1C9YRES MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PREFERRED PHARMACEUTICALS, INC] 7 hydrochloric acid INACTIVE INGREDIENT QTT17582CB MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PREFERRED PHARMACEUTICALS, INC] 7 Methylparaben INACTIVE INGREDIENT A2I8C7HI9T MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PREFERRED PHARMACEUTICALS, INC] 7 Polyethylene glycol 3350 INACTIVE INGREDIENT G2M7P15E5P MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PREFERRED PHARMACEUTICALS, INC] 7 Polysorbate 80 INACTIVE INGREDIENT 6OZP39ZG8H MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PREFERRED PHARMACEUTICALS, INC] 7 Propylparaben INACTIVE INGREDIENT Z8IX2SC1OH MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PREFERRED PHARMACEUTICALS, INC] 7 Sodium chloride INACTIVE INGREDIENT 451W47IQ8X MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PREFERRED PHARMACEUTICALS, INC] 7 sodium hydroxide INACTIVE INGREDIENT 55X04QC32I MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PREFERRED PHARMACEUTICALS, INC] 7 Water INACTIVE INGREDIENT 059QF0KO0R MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PREFERRED PHARMACEUTICALS, INC] 7 MEDROXYPROGESTERONE ACETATE ACTIVE INGREDIENT C2QI4IOI2G MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.] 1 MEDROXYPROGESTERONE ACTIVE MOIETY HSU1C9YRES MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.] 1 HYDROCHLORIC ACID INACTIVE INGREDIENT QTT17582CB MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.] 1 METHYLPARABEN INACTIVE INGREDIENT A2I8C7HI9T MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.] 1 POLYETHYLENE GLYCOL 3350 INACTIVE INGREDIENT G2M7P15E5P MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.] 1 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.] 1 PROPYLPARABEN INACTIVE INGREDIENT Z8IX2SC1OH MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.] 1 SODIUM CHLORIDE INACTIVE INGREDIENT 451W47IQ8X MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.] 1 SODIUM HYDROXIDE INACTIVE INGREDIENT 55X04QC32I MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.] 1 WATER INACTIVE INGREDIENT 059QF0KO0R MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION [PHYSICIANS TOTAL CARE, INC.] 1
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 59762-4537-1 59762453701 1 VIAL in 1 CARTON (59762-4537-1) > 1 mL in 1 VIAL 1 vial 1992-10-29 0000-00-00 No No Current 59762-4537-2 59762453702 25 VIAL in 1 CARTON (59762-4537-2) > 1 mL in 1 VIAL 25 vial 1992-10-29 0000-00-00 No No Current